Article info

Download PDFPDF

208:poster Cost-effectiveness of integrated treatment for hepatitis C virus (HCV) among people who inject drugs in Norway: an economic evaluation of the INTRO-HCV trial

Authors

  • Aaron G Lim Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK PubMed articlesGoogle scholar articles
  • Christer Frode Aas Bergen Addiction Research group, Department of Addiction Medicine, Haukeland University Hospital, Østre Murallmenningen 7, N-5012 Bergen, Norway Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway PubMed articlesGoogle scholar articles
  • Ege Su Çağlar Bergen Addiction Research group, Department of Addiction Medicine, Haukeland University Hospital, Østre Murallmenningen 7, N-5012 Bergen, Norway Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway PubMed articlesGoogle scholar articles
  • Jørn-Henrik Vold Bergen Addiction Research group, Department of Addiction Medicine, Haukeland University Hospital, Østre Murallmenningen 7, N-5012 Bergen, Norway Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway PubMed articlesGoogle scholar articles
  • Lars Thore Fadnes Bergen Addiction Research group, Department of Addiction Medicine, Haukeland University Hospital, Østre Murallmenningen 7, N-5012 Bergen, Norway Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway PubMed articlesGoogle scholar articles
  • Kjell Arne Johansson Bergen Addiction Research group, Department of Addiction Medicine, Haukeland University Hospital, Østre Murallmenningen 7, N-5012 Bergen, Norway Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway PubMed articlesGoogle scholar articles
  • Peter Vickerman Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK PubMed articlesGoogle scholar articles

Citation

Lim AG, Aas CF, Çağlar ES, et al
208:poster Cost-effectiveness of integrated treatment for hepatitis C virus (HCV) among people who inject drugs in Norway: an economic evaluation of the INTRO-HCV trial

Publication history

  • First published April 28, 2022.
Online issue publication 
April 28, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.